A Delayed Diagnosis of Eosinophilic Esophagitis With Downstream Effects
Abstract
Symptoms of eosinophilic esophagitis (EoE) and gastroesophageal reflux disease (GERD) can overlap, and proton pump inhibitors (PPIs) are often started empirically for esophageal symptoms. Despite guideline recommendations to perform endoscopy off PPI therapy, endoscopy in clinical practice is commonly performed while patients are on PPIs which can mask endoscopic findings of EoE and GERD and obscure the diagnosis. This case highlights the importance of discontinuing PPI therapy before endoscopy to optimize the diagnostic yield for EoE and GERD, while demonstrating the significant potential consequences of a missed diagnosis.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
- Ivth brazilian consensus conference on helicobacter pylori infection
- A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia
- S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – März 2023 – AWMF-Registernummer: 021–013
- Step-by-step management of refractory gastresophageal reflux disease
- Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.